A primate model for the study of hallucinogens.
Pharmacology, Biochemistry, and Behavior February 1986 DOI: 10.1016/0091-3057(86)90368-0 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Animal model study Peer reviewed |
|---|---|
| Population | Primate social colonies (monkeys) |
| Interventions | 5-methoxy N N-dimethyltryptamine serotonin antagonists dopamine antagonists physostigmine |
| Key points | Limb jerks were selectively induced by three classes of hallucinogens at doses correlating with human hallucinogenic doses, while non-hallucinogenic congeners did not significantly elicit this response. Tolerance developed to all hallucinogens tested except two, and cross-tolerance was demonstrated. No single drug completely reversed the behavioral abnormalities induced by 5-methoxy N,N-dimethyltryptamine. |
Abstract
An animal model for studying the actions of hallucinogenic drugs using primate social colonies is presented. Although hallucinogens induce a number of behavioral changes in this paradigm, one emergent behavior, limb jerks, appears to be selectively induced by three classes of hallucinogens in doses which correlate with those reported to be hallucinogenic in humans. Several non-hallucinogenic congeners of hallucinogens failed to significantly elicit this response. Other behavioral changes induced by hallucinogens in monkeys such as ptosis and social withdrawal may be useful in studying aspects of hallucinogen intoxication other than hallucinations, or psychosis in general. Upon daily administration, tolerance developed to all hallucinogens tested except two, as is seen in humans. Moreover, cross-tolerance between hallucinogens could be demonstrated. Further experiments with the hallucinogen 5-methoxy N,N-dimethyltryptamine revealed that although certain individual behaviors could be antagonized by serotonin antagonists, dopamine antagonists, and physostigmine, no drug completely reversed the behavioral abnormalities induced by this hallucinogen. It is suggested that this paradigm, which offers an hallucinogen-induced behavior which correlates well with the human hallucinogen response and permits observation of a wide variety of other potentially relevant behaviors in primates, may be useful in developing and testing theories of hallucinogenic drug action. It may be especially valuable in view of the present difficulties of conducting hallucinogen research in humans.
Citations in the library
Cited by 10
- Differential tolerance to biological and subjective effects of four closely spaced doses of N,N-dimethyltryptamine in humans Biological Psychiatry May 1, 1996
- Effect of Hallucinogens on Unconditioned Behavior Current Topics in Behavioral Neurosciences 2016
- A narrative synthesis of research with 5-MeO-DMT. Journal of Psychopharmacology March 1, 2022
- Alpha-adrenergic and 5-HT2-serotonergic effects of some beta-phenylethylamines on isolated rat thoracic aorta. General pharmacology 1994
- Behavioural Investigations of Psilocybin in Animals 1962-2021: A Scoping Review bioRxiv (Cold Spring Harbor Laboratory) January 5, 2024
and 5 more in the library
Cites 5
- Acquired and Crossed Tolerance to Mescaline, LSD-25, and BOL-148 Archives of General Psychiatry September 1, 1959
- Evidence for dopamine mediation of submissive gestures in the stumptail macaque monkey. Pharmacology, Biochemistry, and Behavior 1981
- Inhibitory effect of 5-methoxy-N,N-dimethyltryptamine on the synaptosomal uptake of 5-hydroxytryptamine. European Journal of Pharmacology June 3, 1983
- Development of tolerance to repeated administration of 5-methoxy-N,N-dimethyltryptamine in rats. European Journal of Pharmacology January 15, 1985
- Observational Determination of Dose-Response Curves in Hallucinogen-Treated Monkeys International Pharmacopsychiatry August 11, 2017